Atypical Sweet syndrome: skin sinus tracts in an acutely febrile patient after lymphoma treatment: a case report.

Lu, Shi-Ying; Yang, Hui-Fang; Zeng, Qing-Li; Chen, Peng; Chen, Li; Gao, Jing; Gu, Xue-Kui; Lan, Hai; Luo, Man

Lu, Shi-Ying; Yang, Hui-Fang; Zeng, Qing-Li; Chen, Peng; Chen, Li; Gao, Jing; Gu, Xue-Kui; Lan, Hai; Luo, Man.

Afiliación

Lu SY; Department of Hematology, The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, China.
Yang HF; Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Zeng QL; Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Chen P; Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Chen L; Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Gao J; Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Gu XK; Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Lan H; Department of HematologyShunde Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Luo M; Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.

Front Immunol ; 14: 1193808, 2023.

Article en En | MEDLINE | ID: mdl-37342351

Asunto(s)

Fístula; Inmunoconjugados; Linfoma Anaplásico de Células Grandes; Síndrome de Sweet; Humanos; Masculino; Inmunoconjugados/uso terapéutico; Síndrome de Sweet/inducido químicamente; Síndrome de Sweet/diagnóstico; Síndrome de Sweet/tratamiento farmacológico; Brentuximab Vedotina/uso terapéutico; Linfoma Anaplásico de Células Grandes/inducido químicamente; Linfoma Anaplásico de Células Grandes/tratamiento farmacológico; Linfoma Anaplásico de Células Grandes/patología; Fiebre/tratamiento farmacológico; Factor Estimulante de Colonias de Granulocitos

Palabras clave

brentuximab vedotin; drug-induced Sweet syndrome; granulocyte colony-stimulating factor; local sinus ulcer; systemic anaplastic large-cell lymphoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Sweet / Linfoma Anaplásico de Células Grandes / Inmunoconjugados / Fístula Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google